StonvexLoading…
StonvexCore line items from CCEP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | €20.90B | €20.44B | €18.30B | €17.32B |
Operating Income | €2.79B | €2.13B | €2.34B | €2.09B |
Net Income | €1.98B | €1.44B | €1.67B | €1.52B |
EPS (Diluted) | €4.26 | €3.08 | €3.63 | €3.29 |
Total Assets | €29.87B | €31.10B | €29.25B | €29.31B |
Total Liabilities | €21.57B | €22.11B | €21.28B | €21.87B |
Cash & Equivalents | €918.00M | €1.56B | €1.42B | €1.39B |
Free Cash Flow OCF − CapEx | €2.20B | €2.27B | €2.13B | €2.43B |
Shares Outstanding | Not available | Not available | Not available | Not available |